By Tony Fong

NEW YORK (GenomeWeb News) – By now, most life science tool companies have reported their earnings results for the most recently completed quarter. As many of the firms covered by GenomeWeb Daily News reported jumps in revenues year over year, with some improving substantially, many singled out the performance of technologies such as next-generation sequencers, mass spectrometers, and PCR systems not only as revenue drivers for the quarter just ended but also for the future.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.